digital health tools glp-1 weight management Impact of Engagement on Loss Outcomes in Obesity Among Individuals Using and Dual GLP-1/GIP Receptor Agonist Therapy: Retrospective Cohort Service Evaluation Study Lose Weight Fast with GLP-1

Dermal lipogenesis inhibits adiponectin production in human dermal fibroblasts while exogenous adiponectin administration prevents against UVA-induced dermal matrix degradation in human skin

Its weight-management evidence comes largely from the SURMOUNT trial program published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA extending the data to obstructive sleep apnea in 2024

You can also find your plan documents and summary of benefits on your member portal

New indications and more players in the field The number of indications for GLP-1s continues to grow steadily, like Ozempics recent approval for adults with type 2 diabetes and chronic kidney disease, as well as benefits beyond weight and blood sugar management (e.g., peripheral artery disease, liver disease, heart disease , sleep apnea, osteoarthritis)

Someone starting at 250 pounds could lose an additional 1215 pounds with tirzepatide compared to semaglutide